Berlin, Germany (ots) - Single dose palonosetron is effective and safe in preventing chemotherapy-induced nausea and vomiting (CINV) in patients with aggressive non-Hodgkin's lymphomas who undergo moderately emetogenic chemotherapy. Data presented today at the European Haematology Association Congress in Berlin, Germany New data presented today at the EHA ...
Nyon (ots) - Postal market liberalisation routinely leads to unemployment, attacks on working conditions and poorer service for customers, says a study released today by UNI Global Union. UNI is urging the European Union to immediately put a moratorium on the implementation of the 3rd postal directive and start a proper debate on the issue. Competition is not delivering for customers; it is only creating social ...
Lugano, Switzerland (ots) - A new release of the NCCN (National Comprehensive Cancer Network) Clinical Practice Guidelines in Oncology on Antiemesis recommends palonosetron as the "preferred" 5-HT3 antagonist in combination with aprepitant and dexamethasone for prevention of emesis in highly emetic risk ...
Zurich, Switzerland (ots) - A new, innovative study shows that a single dose of palonosetron, the second generation 5-HT3 antagonist, plus dexamethasone not only prevents chemotherapy-induced nausea and vomiting (CINV), but also allows adequate caloric intake in oncology patients. Data presented today at the ESMO ...
Zurich, Swizerland (ots) - Recently, Solianis successfully finalized a series of tests during which patients with diabetes have worn its multisensor device for non-invasive glucose monitoring at home and at work in the office. The results of these real-life tests as well as earlier tests in a more controlled environment have encouraged Solianis to set up the final device and prepare the market introduction for 2010. ...
Manas Petroleum Corp. (MNAP.OB) Baar, Switzerland (ots) - Manas Petroleum Corporation announces both the results of report on the Economic Evaluation and a report on the revised volumetrics for Manas Petroleum's Albanian blocks A, B and D,E. Both reports provide independent evaluations prepared by Gustavson ...
ITERA International Tissue Engineering R
Zurich, (ots) - Solianis' multisensor system for non-invasive Continuous Glucose Monitoring is currently being tested by diabetic patients in the home and work environment. 12 patients have completed a 10-day trial aimed at assessing system reliability. Results indicate that the system tracks glucose in home-use settings and is sensitive to hypoglycemic glucose ...
Kaiseraugst (ots) - A new scientific study has shown that consuming beta-carotene over a long period of time may help to preserve mental fitness by improving how the brain, and more importantly the memory, works. While it has long been acknowledged that eating beta-carotene-rich foods or taking supplements of this antioxidant can help to protect the skin from ...
New data on the mechanism of action of the second generation 5-HT3 antagonist palonosetron presented today at the 33rd ESMO Congress in Stockholm, Sweden Stockholm, Sweden (ots) - New data presented today at the 33rd ESMO (European Society of Medical Oncology) Congress in Stockholm may contribute to explain the reason why palonosetron, a second generation 5-HT3 ...
Zurich (ots) - Solianis is conducting a study in which patients with diabetes are testing a preliminary functional model of the future device for non-invasive glucose monitoring. First results confirm the expected applicability of the multisensor platform in everyday life. Solianis' unique multisensor platform offers an easy and reliable monitoring of changes ...
Kaiseraugst (ots) - If "an apple a day keeps the doctor away", a carrot a day might help to keep the sun burn away. That is the conclusion of a recently published analysis by Professors Wolfgang Köpcke and Jean Krutmann, of Münster University Hospital and the Institut für Umweltmedizinische Forschung in Düsseldorf, Germany, respectively. In a paper ...
Zürich (ots) - Solianis sees its Multi-Sensor Technology as a promising approach to continuous non-invasive glucose monitoring. Professor Marc Donath, member of the Solianis Scientific Advisory Board and Professor for endocrinology and diabetology at the University Hospital in Zürich, Switzerland, has ...
ASIP - Schweizerischer Pensionskassenverband
- Indication: The performance of Swiss pension funds in 2007 can be downloaded free of charge under: http://www.presseportal.ch/de/pm/100005511/?langid=2 - Zurich (ots) - The performance comparison carried out on behalf of the ...
- Note: The entire press release with graphics can be downloaded free of charge in pdf format at http://www.presseportal.ch/de/pm/100009835?langid=2 - Geneva and Zurich among the world's ten most expensive retail locations Zurich (ots) - Not only are high-class watch and fashion manufacturers using the high demand for luxury products as ...
Baar, Switzerland (ots) - Manas Petroleum Corporation (MNAP.OB) is pleased to announce the results of a Resource Evaluation prepared by Gustavson Associates LLC regarding Manas Petroleum's blocks A, B,D and E in Albania. The Report considers the licenses 8 primary and recognized prospects identified from ...
- Note: The entire press release with graphics (in German) can be downloaded free of charge in pdf format at http://www.presseportal.ch/de/pm/100009835 - Zurich, the city with the highest rents among German-speaking countries and the highest turnovers worldwide Zurich, Switzerland( ots) - Along ...
- The complete research study can be dowloaded free of charge as a pdf at http://www.presseportal.ch/de/pm/100013870/adecco_institute/?langid=2 - First-ever joint European-Chinese study on the Chinese Labor Market illustrates modernization ...
Zurich (ots) - Clear owner strategies and systematic equity management are prerequisites for sustainability In 2006, many Swiss banks increased the value they create for their owners. However, over a seven-year observation period only a small number succeeded in turning their capital to profitable use and achieving profitable growth. These are the findings reached by the Zurich corporate consultancy firm IFBC in ...
Freising-Weihenstephan (ots) - Pieris AG, a biopharmaceutical company developing Anticalins®, a novel class of targeted human protein therapeutics, today announced the appointment of Dr Angelika Stern as Chief Operating Officer to the Company. Pieris has also announced the promotion with immediate effect of ...
Lugano (ots) - Oral Formulations of 5-HT3 receptor Antagonists Represent Approximately 10% of the Day-of-Chemotherapy Market - Helsinn Healthcare SA, a privately owned Swiss pharmaceutical group, and its partner MGI PHARMA, INC., (Nasdaq: MOGN), a biopharmaceutical company focused in oncology and acute care, ...
Basel (ots) - Tobacco or Health. This is not a question but a revelation. Each year, over 5 million people globally die from the consequences of active and passive tobacco consumption - over 650 000 people in the European Union alone. About 8 000 people die per year in Switzerland as a consequence. What are ...
Freising-Weihenstephan, Germany (ots) - Pieris AG, a bio-pharmaceutical company developing Anticalins®, a novel class of targeted human protein therapeutics, today announced successful completion of a series of preclinical studies validating the use of Anticalins® in ophthalmologic disease. The studies reported by Pieris relate to PRS-055, an ...
IEC International Electrotechnical Commission
This news release replaces that of July 17,2007: Please note the corrected numbers in the first paragraph. Geneva (ots) - Studies in the USA indicate that the world's electrical consumption is set to rise to 30 000 billion kWh by 2030 from 15 400 billion kWh in 2006. Governments and utilities today need to plan to supply large amounts of electrical energy ...
Barcelona (ots) - New Results Represent Additional Data From a Study Showing Superior Efficacy of ORENCIA or Infliximab Compared to Placebo at Six Months Bristol-Myers Squibb Company (NYSE: BMY) today announced additional study results providing evidence of the efficacy and durability of response of ORENCIA(R) (abatacept) through 12 months in adults with ...
Anti-Tumor Necrosis Factor (TNF) Therapy in Inadequately Responding Rheumatoid Arthritis Patients Barcelona (ots) - According to a new study, it is possible to safely switch directly to ORENCIA® from anti-TNF therapy in rheumatoid arthritis patients who have had an inadequate response to anti-TNF therapy. The results were announced today by Bristol-Myers ...
Swiss-American Chamber of Commerce & The Boston Consulting Group
Zurich (ots) - One third of the Swiss GDP is at stake in the international competition around business locations. For Switzerland, five key measures are crucial to win the battle. Multinational companies, accounting for 34% of the total GDP, are very important to the Swiss economy. The Swiss-American Chamber of Commerce and The Boston Consulting Group have ...
Freising-Weihenstephan (ots) - Pieris AG, a bio-pharmaceutical company developing therapeutic products comprising of Anticalins®, a novel proprietary class of human binding proteins, announced today it has demonstrated potent anti-tumor activity of PRS-050. The positive results with PRS-050, a VEGF-specific ...
Prion proteins found in commercial milk Schlieren (ots) - In a first-time global breakthrough, a Swiss start-up firm has succeeded in detecting prion proteins in the milk of humans, cows, sheep, and goats. This again raises the question of a "mad cow disease" risk from drinking milk. Tests are underway to verify disease-causing prions in milk. Prions are known to be causes of neurological conditions such as Mad ...